Table 2 ADAM12 expression correlated with clinical pathological characteristics (logistic regression).
From: ADAM12 is an independent predictor of poor prognosis in liver cancer
Characteristics | Total (N) | Odds ratio (OR) | P value |
|---|---|---|---|
T stage (T2 & T3 & T4 vs. T1) | 371 | 1.943 (1.288–2.943) | 0.002 |
N stage (N1 vs. N0) | 258 | 3.298 (0.416–67.150) | 0.304 |
M stage (M1 vs. M0) | 272 | 1.078 (0.128–9.087) | 0.941 |
Pathological stage (Stage III & Stage IV & Stage II vs. Stage I) | 350 | 1.911 (1.252–2.931) | 0.003 |
Tumour status (with tumour vs. tumour-free) | 355 | 1.267 (0.832–1.933) | 0.270 |
Age (> 60 vs. ≤ 60 years) | 373 | 0.748 (0.497–1.124) | 0.163 |
Gender (male vs. female) | 374 | 0.627 (0.403–0.969) | 0.036 |
Histological grade (G3 & G2 & G4 vs. G1) | 369 | 1.748 (0.979–3.185) | 0.062 |
Vascular invasion (yes vs. no) | 318 | 1.330 (0.837–2.117) | 0.228 |
Race (White & Black or African American vs. Asian) | 362 | 1.537 (1.014–2.338) | 0.043 |
Residual tumour (R1 & R2 vs. R0) | 345 | 2.957 (1.088–9.389) | 0.044 |